sarah mitchell
AstraZeneca & Daiichi Sankyo’s Enhertu Posts Positive Data as First-Line Breast Cancer Therapy
A cancer medication of the Astrazeneca and Daiichi Sankyo partners currently approved as a second -line or posterior treatment for…
Medicare Advantage CEO: My baby is ugly…(video)
Direct conversation is what everyone wants, but it is rarely understood. At the Medicarians conference held earlier this month in…
Clinician Adoption: How HealthTech Can Overcome Key Barriers
Health innovation is frequently accompanied with skepticism and resistance, even when it promises to improve patient results and operational efficiency.…
The Price is Wrong: We Need to Solve the Healthcare Insurance Transparency Crisis
He obtains instant confirmation when requesting edible. Tu Tu Uber trails while bending the corner. You know the cost of…
What Are Health Systems’ Strategic Priorities in 2025?
The Health Investor Conference, Medcity Invest, scheduled for May 20 to 21 at the Willis Tower in Chicago, will stop…
Blockbuster Sanofi & Regeneron Drug Dupixent Notches FDA Nod for an Inflammatory Skin Disease
Sanofi and Regeneron Pharmaceuticals Drug Dupixent have won the approval of the FDA for chronic spontaneous urticaria, introducing a new…
How Are Hospitals Bracing for Tariffs?
La industria de la salud se ha enfrentado a una gran cantidad de cambios radicales a nivel federal desde la…
Women’s Health is Having Its Moment – It’s Time for the System to Catch Up
Women's health has been historically marginalized, unavured, underlined often misunderstanding. While interest and investment around the health of complex women…